ITF2357 Interferes with apoptosis and inflammatory pathways in the HL-60 model: A gene expression study

Sara Galimberti, Martina Canestraro, Hakan Savli, Giuseppe Alberto Palumbo, Daniele Tibullo, Balint Nagy, Simona Piaggi, Francesca Guerrini, Naci Cine, Maria Rita Metelli, Mario Petrini

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Cytotoxic and pro-apoptotic effects exerted by the histone deacetylase inhibitor ITF2357 have been reported in acute myeloid leukemia HL-60 cells. In the current study, its mechanism of action was investigated at the molecular level. Materials and Methods: Cell proliferation was evaluated by methyl thiazol tetrazolium bromide reduction; apoptosis by annexin V, mitochondrial transmembrane potential by tetramethylrhodamine ethyl ester. Functional experiments and gene expression evaluations were performed by flow cytometry, microarray, and quantitative polymerase chain reaction. Results: Significant cell growth inhibition and increased apoptosis were observed. ITF2357 reduced protein levels of BCL-2, MCL-1, and BCL-X, and increased levels of BAK. Exposure. to ITF2357 did not abrogate NF-κB DNA binding. After microarray analysis, interleukin-10, interleukin-6, epidermal growth factor, peroxisome proliferator-activated receptor (PPAR), transforming growth factor β, P38 mitogen-activated protein kinase, aryl hydrocarbon receptor, xenobiotic metabolism, PPAR/retinoic acid receptor, NF-κB, apoptosis, lipopolysaccharide/interleukin-1, G-protein receptor, T-cell receptor, and platelet-derived growth factor were the de-regulated pathways. Conclusion: This study shows that ITF2357 influences both proliferation and inflammatory pathways in HL-60 cells; this observation could have possible applications in clinical practice.

Original languageEnglish
Pages (from-to)4525-4535
Number of pages11
JournalAnticancer research
Volume30
Issue number11
Publication statusPublished - Nov 1 2010

Keywords

  • Apoptosis
  • Gene expression
  • Histone deacetylase inhibitor
  • ITF2357
  • Inflammation
  • NF-κB

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'ITF2357 Interferes with apoptosis and inflammatory pathways in the HL-60 model: A gene expression study'. Together they form a unique fingerprint.

  • Cite this

    Galimberti, S., Canestraro, M., Savli, H., Palumbo, G. A., Tibullo, D., Nagy, B., Piaggi, S., Guerrini, F., Cine, N., Metelli, M. R., & Petrini, M. (2010). ITF2357 Interferes with apoptosis and inflammatory pathways in the HL-60 model: A gene expression study. Anticancer research, 30(11), 4525-4535.